Announcements Trials
Browse Landscape

Phase

Phase 2 4

Status

Unknown 5Recruiting 4Completed 3Not yet recruiting 2

Sponsor Class

OTHER 5

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Gastrointestinal 77Thoracic 29Head & Neck 12Lymphoid 6Gynecologic 5Other solid neoplasm 3Genitourinary 3CNS 3Breast 3Tumor-Agnostic 2Endocrine 2Sarcoma 1Other neoplasm 1NET 1Myeloid 1Dermatologic 1

Conditions

Uterine Cervical Neoplasms 3Recurrent/ Advanced Stage Endometrial Cancer Patients 1Locally Advanced Cervical Carcinoma 1

Interventions

Paclitaxel 77Carboplatin 71Cisplatin 70Radiotherapy 27Bevacizumab 27Brachytherapy 23Hyperthermic Intraperitoneal Chemotherapy 20Drug Therapy 20olaparib 18Gemcitabine 17niraparib 16apatinib 16pembrolizumab 15Surgical Procedures, Operative 14liposomal doxorubicin 12Cyclophosphamide 12Surveys and Questionnaires 11camrelizumab 10Neoadjuvant Therapy 10fludarabine 9anlotinib 9Taxes 9Etoposide 9Blood Specimen Collection 9Topotecan 8Docetaxel 8Sentinel Lymph Node Biopsy 7Platinum 7Cytoreduction Surgical Procedures 7Albumin-Bound Paclitaxel 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Unknown × sintilimab × Gynecologic × Clear all
NCT06378840 2024-04-23

the Predictive Value of Immune Cell in Locally Advanced Cervical Cancer

RenJi Hospital

Unknown
20 enrolled
Gynecologic

Locally Advanced Cervical Carcinoma

NCT05105672 2021-12-28

A Study of Sintilimab Combined With Concurrent Chemoradiation Therapy in Locally Advanced Cervical Cancer

The Affiliated Hospital of Xuzhou Medical University

Phase 2 Unknown
20 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT04885413 2021-08-23

An Open-label, Single Arm, Phase II Trial of Niraparib in Combination With Anti-PD1(Programmed Cell Death Protein 1) Antibody in Recurrent/ Advanced Stage Endometrial Cancer Patients

Sun Yat-sen University

Phase 2 Unknown
37 enrolled
Gynecologic

Recurrent/ Advanced Stage Endometrial Cancer Patients

NCT04918628 2021-06-09

CRTCP

Taizhou Hospital

Phase 2 Unknown
50 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT04096911 2019-09-20

Combination of PD-1 Monoclonal Antibody and HPV Vaccine in Patients With Cervical Cancer

Northern Jiangsu People's Hospital

Phase 2 Unknown
20 enrolled
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡